Stock-Based Compensation (Tables)
|
6 Months Ended |
Jul. 31, 2025 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock Option Activity |
A summary of the Company’s stock option activity for the six months ended July 31, 2025 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Stock Options |
|
Weighted Average Exercise Price |
|
Weighted Average Remaining Contractual Life |
|
(in thousands) |
|
|
|
(in years) |
Outstanding as of January 31, 2025 |
18,572 |
|
|
$ |
6.60 |
|
|
4.7 |
|
|
|
|
|
|
| Exercised |
(2,753) |
|
|
4.70 |
|
|
|
Forfeited |
(1,060) |
|
|
10.97 |
|
|
|
| Expired |
(2) |
|
|
1.71 |
|
|
|
Outstanding as of July 31, 2025 |
14,757 |
|
|
$ |
6.64 |
|
|
4.6 |
|
|
|
|
|
|
Exercisable as of July 31, 2025 |
14,067 |
|
|
$ |
6.35 |
|
|
4.4 |
Vested and expected to vest as of July 31, 2025 |
14,751 |
|
|
$ |
6.64 |
|
|
4.6 |
|
| Schedule of RSU Award Activity |
A summary of the Company’s RSU activity for the six months ended July 31, 2025 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Restricted Stock Units |
|
Weighted Average Grant Date Fair Value |
|
(in thousands) |
|
|
Outstanding as of January 31, 2025 |
14,750 |
|
|
$ |
10.46 |
|
| Granted |
11,408 |
|
|
8.92 |
|
| Released |
(2,989) |
|
|
11.72 |
|
Cancelled/forfeited |
(2,509) |
|
|
11.19 |
|
Outstanding as of July 31, 2025 |
20,660 |
|
|
$ |
9.34 |
|
|
| Schedule of Performance Based Stock Units |
A summary of the Company’s PSU activity for the six months ended July 31, 2025 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Performance Stock Units |
|
Weighted Average Grant Date Fair Value |
|
(in thousands) |
|
|
Outstanding as of January 31, 2025 |
2,918 |
|
|
$ |
8.31 |
|
| Granted |
810 |
|
|
12.91 |
|
|
|
|
|
Cancelled/forfeited |
(280) |
|
|
8.06 |
|
Outstanding as of July 31, 2025 |
3,448 |
|
|
$ |
9.41 |
|
|
| Schedule of Fair Value of PSUs Granted |
To determine the fair value of the 2024 and 2025 PSUs, the Company utilized a Monte Carlo simulation. The inputs included in the valuations were as follows:
|
|
|
|
|
|
|
|
| Vest-term |
Three years |
| Volatility |
48.8% - 53.7% |
| Risk-free rate |
3.91% - 4.22% |
| Fair value of common stock at grant date |
$8.21 - $9.14 |
| Dividend yield |
0% |
| Expected term |
Three years |
| Fair value valuation |
$11.82 - $14.84 |
|
| Schedule of Stock-based Compensation Expense |
Stock-based compensation expense included in operating results was allocated as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended July 31, |
|
Six Months Ended July 31, |
| (in thousands) |
2025 |
|
2024 |
|
2025 |
|
2024 |
| Costs of subscription |
$ |
223 |
|
|
$ |
327 |
|
|
$ |
488 |
|
|
$ |
610 |
|
| Costs of professional services |
726 |
|
|
364 |
|
|
1,118 |
|
|
681 |
|
| Research and development |
4,204 |
|
|
2,834 |
|
|
8,090 |
|
|
5,408 |
|
| Sales and marketing |
6,124 |
|
|
5,802 |
|
|
12,419 |
|
|
11,406 |
|
| General and administrative |
10,027 |
|
|
5,765 |
|
|
19,603 |
|
|
10,842 |
|
Restructuring |
— |
|
|
— |
|
|
866 |
|
|
— |
|
| Stock-based compensation, net of amounts capitalized |
21,304 |
|
|
15,092 |
|
|
42,584 |
|
|
28,947 |
|
| Capitalized stock-based compensation |
388 |
|
|
631 |
|
|
1,305 |
|
|
1,182 |
|
| Total stock-based compensation |
$ |
21,692 |
|
|
$ |
15,723 |
|
|
$ |
43,889 |
|
|
$ |
30,129 |
|
|